Biovie (BIVI) Shares Outstanding (Entity) (2013 - 2026)
Biovie's Shares Outstanding (Entity) came in at 7.54 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 410.5% from 1.48 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends
Going back to fiscal Q4 2013, Biovie's Shares Outstanding (Entity) data covers 52 quarters.
- Shares Outstanding (Entity) has increased in each of the last six fiscal years, with a five-year compound annual growth rate of 127.4% (FY2021 to FY2026).
- Going back by fiscal year, Shares Outstanding (Entity) was 1.48 million in FY2025 (+227.0%), 451,853 in FY2024 (+24.0%), 364,289 in FY2023 (+45.8%) and 249,841 in FY2022 (+101.4%).
- The fiscal Q4 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q4 2013.
- Year-over-year, Shares Outstanding (Entity) has increased for 24 consecutive quarters, with growth averaging 339.8% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 15.5% (fiscal Q2 2024) and 715.0% (fiscal Q1 2026) over the last five years.
- Business Quant data shows BIVI's Shares Outstanding (Entity) at 7.54 million (Q3 2026), 7.54 million (Q2 2026) and 5.21 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Biovie | 11.46 Mn | 11.46 Mn | - | 7.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.54 Mn |
| Mar 31, 2026 | 7.54 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Sep 30, 2025 | 5.21 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 639,836.00 |
| Jun 30, 2024 | 451,853.00 |
| Mar 31, 2024 | 448,011.00 |
| Dec 31, 2023 | 398,438.00 |
| Sep 30, 2023 | 369,228.00 |
| Jun 30, 2023 | 364,289.00 |
| Mar 31, 2023 | 361,313.00 |
| Dec 31, 2022 | 345,043.00 |
| Sep 30, 2022 | 301,653.00 |
| Jun 30, 2022 | 249,841.00 |
| Mar 31, 2022 | 249,841.00 |
| Dec 31, 2021 | 249,841.00 |
| Sep 30, 2021 | 249,624.00 |
API Access
Biovie Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();